awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q51584924-0B6BCBC7-86D1-42D3-A889-837BDE21BF86
Q51584924-0B6BCBC7-86D1-42D3-A889-837BDE21BF86
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51584924-0B6BCBC7-86D1-42D3-A889-837BDE21BF86
Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegol.
P2860
Q51584924-0B6BCBC7-86D1-42D3-A889-837BDE21BF86
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51584924-0B6BCBC7-86D1-42D3-A889-837BDE21BF86
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fd9ccdfe9ad628bb801de910016130db5c0e34ed
P2860
Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab.